GTS Securities sliced its Amgen stake by over half, dumping 6,541 shares and leaving just 5,117 shares worth $1.3 million.

The biotech pioneer posted strong Q1 2025 results with 14 drugs delivering double-digit sales growth. Amgen (NASDAQ: AMGN) is ...

Many Amgen Inc. (NASDAQ:AMGN) insiders ditched their stock over the past year, which may be of interest to the company's ...

Waverly Advisors has upped its stake in Amgen by nearly 18%, bringing its total holdings to over $8 million. Other ...

With so many variables, some investors may prefer to find stocks that generate reliable passive income through dividends.

Despite these positive clinical developments, Amgen and Viking Therapeutics have performed poorly on the stock market in the past 12 months, though progress in this area might eventually help them ...

This was the stock's second consecutive day of losses.

AMGN's consistent top-line growth, an interesting pipeline and rising estimates are good enough reasons to stay invested in ...

Marjorie Taylor Greene disclosing buying 19 different stocks in a new filing. The buys come less than two weeks after the ...

Amgen AMGN and Bristol Myers Squibb BMY are among the largest global biotechnology companies with broad and diverse ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...